Precipio, Inc.
- PRPO
- NASDAQ
- Medical - Diagnostics & Research
- Cancer Diagnostics
- Lab Testing
$21.89
Today +2.41%Quote Oct 19, 2026, 08:00 PM UTC
−17.27%over the last month
Max drawdown −20.2%From 1-month high −18.3%3 months −7.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Precipio
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers.
Where the money comes from
Q2 2026 revenue $20.2M
- Service revenue, net$14.1M69.8%
- Diagnostic Testing$6.1M30.2%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
61
Market value
$39.2M
Quote Oct 19
Floor
$20.78
5.1% below price
Resistance
$21.98
0.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PRPOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free